Avalyn Pharma Inc. (AVLN) stock
AVLNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$27.69−0.23 (-0.82%)
Close on Nov 18, 2026Market cap $1.23BP/E –Yield –
Avalyn Pharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for Avalyn Pharma
Avalyn Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?